Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01XK" (17)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Olaparib (L01XK01) 4 products
WHO-DDD
L
IP
CI
Lynparza 100 mg
112
4585.23
5003.15
10 %
Coated tablets: Olaparibum 100 mg
AstraZeneca AG
A / SL
FB
G
L
IP
CI
Lynparza 150 mg
112
4585.23
5003.15
10 %
Coated tablets: Olaparibum 150 mg
AstraZeneca AG
A / SL
FB
G
IP
CI
Lynparza 100 mg
56
k.A.
Coated tablets: Olaparibum 100 mg
AstraZeneca AG
A
FB
G
IP
CI
Lynparza 150 mg
56
k.A.
Coated tablets: Olaparibum 150 mg
AstraZeneca AG
A
FB
G
Niraparib (L01XK02) 2 products
WHO-DDD
L
IP
CI
Zejula 100 mg
56
3940.93
4302.40
10 %
Coated tablets: Niraparibum 100 mg
GlaxoSmithKline AG
A / SL
FB
G
L
IP
CI
Zejula 100 mg
84
5911.40
6372.90
10 %
Coated tablets: Niraparibum 100 mg
GlaxoSmithKline AG
A / SL
FB
G
Rucaparib (L01XK03) 6 products
WHO-DDD
L
IP
CI
Rubraca 200 mg
60
1823.35
1999.40
10 %
Coated tablets: Rucaparibum 200 mg
mmpharm GmbH
A / SL
FB
G
L
IP
CI
Rubraca 200 mg
120
3646.70
3982.40
10 %
Coated tablets: Rucaparibum 200 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 250 mg
60
2279.19
2495.15
10 %
Coated tablets: Rucaparibum 250 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 250 mg
120
4558.38
4973.95
10 %
Coated tablets: Rucaparibum 250 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 300 mg
60
2735.03
2990.95
10 %
Coated tablets: Rucaparibum 300 mg
mmpharm GmbH
A / SL
FB
G
L
IP
Rubraca 300 mg
120
5470.06
5920.10
10 %
Coated tablets: Rucaparibum 300 mg
mmpharm GmbH
A / SL
FB
G
Talazoparib (L01XK04) 5 products
WHO-DDD
L
IP
CI
Talzenna 0.25 mg
30
1557.04
1709.80
10 %
Capsules: Talazoparibum
Pfizer AG
A / SL
FB
G
L
IP
CI
Talzenna 0.5 mg
30
2646.97
2895.15
10 %
Capsules: Talazoparibum
Pfizer AG
A / SL
FB
G
L
IP
CI
Talzenna 1 mg
30
4674.98
5100.75
10 %
Capsules: Talazoparibum 1 mg
Pfizer AG
A / SL
FB
G
IP
CI
Talzenna 0.1 mg
30
k.A.
Capsules: Talazoparibum
Pfizer AG
A
FB
G
IP
CI
Talzenna 0.35 mg
30
k.A.
Capsules: Talazoparibum
Pfizer AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home